Company Description
KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic.
KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.
Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare.
The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.
Beyond its treatment of patients, KindlyMD collects data focused on why and how patients turn to alternative treatments to reduce prescription medication use and addiction.
The Company captures all relevant datapoints to assist and appropriately treat each individual patient.
We strive to become a source for evidence-based guidelines, data, treatment models, and education in the fight against the opioid crisis in America.
Country | United States |
Founded | 2019 |
IPO Date | May 31, 2024 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 21 |
CEO | Timothy Pickett |
Contact Details
Address: 5097 South 900 East, Suite 100 Salt Lake City, UT 84117 United States | |
Phone | (385) 388-8220 |
Website | kindlymd.com |
Stock Details
Ticker Symbol | KDLY |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $5.50 |
CIK Code | 0001946573 |
Employer ID | 84-3829824 |
SIC Code | 8000 |
Key Executives
Name | Position |
---|---|
Timothy Pickett | Chief Executive Officer, Director |
Adam Cox | Chief Operating Officer, Director |
Jared Barrera | Chief Financial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 31, 2024 | 8-K | Current Report |
May 31, 2024 | 424B4 | Prospectus |
May 31, 2024 | 424B3 | Prospectus |
May 31, 2024 | CERT | Certification by an exchange approving securities for listing |
May 15, 2024 | 424B4 | Prospectus |
May 15, 2024 | 424B3 | Prospectus |
May 13, 2024 | EFFECT | Notice of Effectiveness |
May 13, 2024 | 8-A12B | Registration of securities |
May 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Apr 9, 2024 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |